Heart patients do better with non-surgical valve replacement than standard medical therapy

March 26, 2012, Cedars-Sinai Medical Center

Patients diagnosed with aortic stenosis who are too sick for open-heart surgery have better survival rates and an improved quality of life after undergoing catheter-based heart valve replacement than if the patients had been treated with standard medical therapy, according to a study authored by a Cedars-Sinai Heart Institute physician based on results from a multicenter clinical trial.

The study, published online today by the , will appear in the May 3 print edition of the journal.

"This study shows that this minimally invasive procedure adds years to life and life to years," said Raj Makkar, MD, associate director of the Cedars-Sinai Institute and the Stephen R. Corday, MD, Chair in Interventional Cardiology.

, a stiffening of the aortic valve's three flaps, restricts the flow of blood from the heart to the rest of the body. It forces the heart to work harder and deprives the organs of sufficient oxygen-rich blood. Aortic stenosis affects an estimated 2 to 9 percent of U.S. adults 65 and older. The condition can cause chest pains, shortness of breath, dizziness and fainting.

Before catheter-based heart valve procedures were developed in the last decade, patients diagnosed with aortic stenosis would have just one option to repair a malfunctioning valve: Open-heart surgery.

However, about a third of patients are too frail for open heart surgery. And without it, patients with aortic stenosis can expect to die from within five years and often much sooner.

In percutaneous or minimally invasive heart valve procedures, physicians use the vascular system's network of "highways" -- the arteries -- to reach the heart instead.

Physicians insert a thin tube, or catheter, through a small incision in the groin or the side of the chest. The catheter, which contains a compressed artificial , is threaded along the arteries all the way to the heart. Once the valve is precisely positioned in the heart, a balloon nestled inside the valve – similar to the kind used for angioplasties -- is inflated. The balloon pops the valve open, like an umbrella, to its full diameter.

Cedars-Sinai's Heart Institute is a global leader in seeking nonsurgical solutions for malfunctioning heart valves. Physicians at the Heart Institute, in conducting multiple clinical trials, have performed more of these catheter-based valve procedures than doctors at any other U.S. medical center.

In the clinical trial, which was funded by valve manufacturer Edwards Lifesciences, 358 patients at 21 medical centers were randomized into two groups. One group underwent percutaneous procedures. The other group received standard medical treatment, including prescription drugs. Both groups were followed for two years.

Results include:

  • Two years after being diagnosed, 68 percent of patients receiving standard medical therapy had died, compared to just 43 percent of patients who received the minimally invasive procedure.
  • 33 percent of patients who received the minimally were readmitted to the hospital at some point during the two years of follow up, compared to 72 percent of patients who received medical therapy.
  • Patients who underwent the procedure did have a higher risk of stroke, with 14 percent suffering a stroke, compared to just 5 percent of standard therapy patients.
Other than reimbursement for travel to medical centers participating in the clinical trial, Makkar has received no payment from Edwards Lifesciences.

Open-heart surgery to repair or replace heart valves is still the "gold standard," says Eduardo Marbán, director of the Cedars-Sinai Heart Institute and the Mark S. Siegel Family Professor, who adds that demand for catheter-based procedures is growing.

"The heart's valves wear out as you age," Marbán said. "And the older you are generally makes you a less attractive candidate for . This new, less-invasive option will become more and more important to patients as the Baby Boom Generation ages."

Explore further: UofL physicians, Jewish Hospital first in Kentucky to offer new aortic valve replacement

Related Stories

UofL physicians, Jewish Hospital first in Kentucky to offer new aortic valve replacement

January 3, 2012
Some individuals with severe aortic stenosis – also known as narrowing of the aortic valve in the heart – who are not well enough to undergo open heart surgery have a new treatment option thanks to a new procedure ...

Heart valve replacement without opening the chest gives new option for non-operable patients

June 24, 2011
An innovative approach for implanting a new aortic heart valve without open-heart surgery is being offered at Rush University Medical Center to patients with severe aortic stenosis who are at high-risk or not suitable candidates ...

New option for patients with untreatable, non-perative heart condition

June 28, 2011
(Medical Xpress) -- An innovative approach for implanting a new aortic heart valve without open-heart surgery is being offered at Rush University Medical Center to patients with severe aortic stenosis who are at high-risk ...

Recommended for you

Biomechanical mapping method aids development of therapies for damaged heart tissue

January 23, 2018
Researchers have developed a new way to capture the detailed biomechanical properties of heart tissue. The high-resolution optical technique fills an important technology gap necessary to develop and test therapies that might ...

Researchers borrow from AIDS playbook to tackle rheumatic heart disease

January 22, 2018
Billions of US taxpayer dollars have been invested in Africa over the past 15 years to improve care for millions suffering from the HIV/AIDS epidemic; yet health systems on the continent continue to struggle. What if the ...

A nanoparticle inhalant for treating heart disease

January 18, 2018
A team of researchers from Italy and Germany has developed a nanoparticle inhalant for treating people suffering from heart disease. In their paper published in the journal Science Translational Medicine, the group describes ...

Starting periods before age of 12 linked to heightened risk of heart disease and stroke

January 15, 2018
Starting periods early—before the age of 12—is linked to a heightened risk of heart disease and stroke in later life, suggests an analysis of data from the UK Biobank study, published online in the journal Heart.

'Decorated' stem cells could offer targeted heart repair

January 10, 2018
Although cardiac stem cell therapy is a promising treatment for heart attack patients, directing the cells to the site of an injury - and getting them to stay there - remains challenging. In a new pilot study using an animal ...

Exercise is good for the heart, high blood pressure is bad—researchers find out why

January 10, 2018
When the heart is put under stress during exercise, it is considered healthy. Yet stress due to high blood pressure is bad for the heart. Why? And is this always the case? Researchers of the German Centre for Cardiovascular ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.